Production and radiochemical purity of 177Lu-PSMA-617 for clinical trial

被引：0
|
作者：
Asad, Ali [1 ]
Scharli, Rainer [2 ]
Morandeau, Laurence [1 ]
Price, Roger [3 ]
机构：
[1] Sir Charles Gairdner Hosp, Nedlands, WA, Australia
[2] Univ Western Australia, Nedlands, WA, Australia
[3] Sir Charles Gairdner Hosp, Med Technol & Phys, Nedlands, WA, Australia
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
P-358
引用
收藏
页码：S527 / S527
页数：1
相关论文
共 50 条
  • [1] 177LU-PSMA-617 PRODUCTION AND QUALITY CONTROL AT THE RAH
    Girvin, Mark
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 14 - 14
  • [2] 177Lu-PSMA-617: Brazilian Experience
    Villas Boas, Cristian Wieczorek
    Silva, Jefferson de Jesus
    Benedetto, Raquel
    Mengatti, Jair
    De Araujo, Elaine Bortoleti
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [3] Maintaining radiochemical purity of 177Lu-DOTA-PSMA-617 for PRRT
    De Zanger, Rory
    Chan, Ho Sze
    Breeman, Wouter
    de Blois, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [4] Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
    Jadvar, Hossein
    Iravani, Amir
    Bodei, Lisa
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1851 - 1854
  • [5] Administration of 177Lu-PSMA-617 as Compared to 177Lu-Dotatate
    Patel, P.
    McCall, K.
    MEDICAL PHYSICS, 2022, 49 (06) : E811 - E812
  • [6] Dose Escalation Experience with 177Lu-PSMA-617
    Rathke, H.
    Giesel, F. L.
    Flechsig, P.
    Kopka, K.
    Mier, W.
    Hohenfellner, M.
    Haberkorn, U.
    Kratochwil, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S280 - S281
  • [7] 177Lu-PSMA-617 vs Cabazitaxel in MCRPC
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (04) : 13N - 13N
  • [8] A Hangover Under 177Lu-PSMA-617 Therapy
    Poterszman, Nathan
    Somme, Laura
    Bund, Caroline
    Hutt, Emilie
    Somme, Francois
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 582 - 583
  • [9] Radiation Dosimetry in 177Lu-PSMA-617 Therapy
    Jackson, Price
    Hofman, Michael
    McIntosh, Lachlan
    Buteau, James Patrick
    Kumar, Aravind Ravi
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (02) : 243 - 254
  • [10] Evaluation of 177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective 177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)
    Pathmanandavel, Sarennya
    Crumbaker, Megan
    Ho, Bao
    Yam, Andrew O.
    Wilson, Peter
    Niman, Remy
    Ayers, Maria
    Sharma, Shikha
    Hickey, Adam
    Eu, Peter
    Stockler, Martin
    Martin, Andrew J.
    Joshua, Anthony M.
    Nguyen, Andrew
    Emmett, Louise
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (02) : 221 - 226
12345